CH373386A - Process for the preparation of new 1,3-disubstituted phenothiazine derivatives - Google Patents

Process for the preparation of new 1,3-disubstituted phenothiazine derivatives

Info

Publication number
CH373386A
CH373386A CH6724258A CH6724258A CH373386A CH 373386 A CH373386 A CH 373386A CH 6724258 A CH6724258 A CH 6724258A CH 6724258 A CH6724258 A CH 6724258A CH 373386 A CH373386 A CH 373386A
Authority
CH
Switzerland
Prior art keywords
disubstituted
formula
preparation
phenothiazine
new
Prior art date
Application number
CH6724258A
Other languages
German (de)
Inventor
Jaromir Dipl-Ing Dr Hebky
Jiri Dr Kejha
Otto Dipl Ing Radek
Original Assignee
Spofa Vereinigte Pharma Werke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spofa Vereinigte Pharma Werke filed Critical Spofa Vereinigte Pharma Werke
Publication of CH373386A publication Critical patent/CH373386A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

Description

  

  Verfahren zur Herstellung von neuen     1,3-disubstituierten        Phenothiazinabkömmlingen       Gegenstand der Erfindung ist ein Verfahren zur  Herstellung von     1,3-disubstituierten        Phenothiazin-          abkömmlin2en    der Formel  
EMI0001.0006     
    wobei X und Y gleiche oder verschiedene     Alkyl-    oder       Alkoxylreste,    wie     Methyl-    oder     Methylreste,    oder  einer dieser     Substituenten    ein Halogenatom, vor  zugsweise Chlor, A einen geraden oder verzweigten       Alkylenrest    mit 2-6     C-Atomen,

          R1    und     R2    gleiche  oder verschiedene niedermolekulare     Alkylreste    be  deuten, welche mit dem     N-Atom    ein     heterocycli-          sches    Ringsystem, das noch ein weiteres     Heteroatom     enthalten kann, bilden können, das dadurch gekenn  zeichnet ist, dass man     1,3-disubstituierte        Phenothia-          zine    der Formel  
EMI0001.0024     
    mit     Aminoalkylhalogeniden    der Formel  
EMI0001.0026     
    wobei     Hal    ein Halogenatom bedeutet, oder     1,

  3-di-          substituierte        Phenothiazine    der Formel  
EMI0001.0031     
    mit sekundären Aminen der Formel  
EMI0001.0032     
    kondensiert.  Als sekundäres Amin der Formel  
EMI0001.0033     
    kann man z. B.     Dimethylamin,        Piperidin    und ähn  liche Verbindung verwenden.  



  Diese Verbindungen sind neu. Bei geringer     Toxi-          zität    besitzen sie     lokalanästhetische,    sedative,     ata-          raktische    und potenzierende Wirksamkeit, welche  z. B. bei der     Thiobarbituratnarkose    besonders aus  geprägt ist.  



  Die Kondensationen werden vorteilhaft in Gegen  wart von säurebindenden Mitteln, z. B. Alkali  metallen, ihren     Hydroxyden,        Amiden,    Hydriden,       Alkoholaten    oder     Organometallverbindungen    und in  einem     inerten    organischen Lösungsmittel, z. B.     Xylol,     durchgeführt. Die Kondensation verläuft auch ohne  Lösungsmittel und ohne säurebindende Mittel.

   Die           Alkylaminoalkylhalogenide    kann man auch in     Form          ihrer        Salze        mit    starken Mineralsäuren verwenden,  aber in diesem Falle ist ein Zusatz von säurebinden  den     Mitteln    in entsprechender Menge erforderlich.  



  Die neuen, erfindungsgemäss dargestellten Verbin  dungen können in Form ihrer wasserlöslichen Salze       mit    organischen oder     anorganischen    Säuren oder  in Form wasserlöslicher     Anlagerungsverbindungen     verabreicht werden.  



  <I>Beispiel 1</I>  Zu einer Lösung von 6,8 g     1,3-Dimethyl-pheno-          thiazin        (F.    147  C) in 40     ml        Xylol    setzt man 1,2 g  fein zerriebenes     Natriumamid        80%ig    zu und erhitzt  die Mischung unter Rühren 2 Stunden auf 130  C.  Hierzu tropft man dann innerhalb 1 Stunde eine  Lösung von 4 g     3-Dimethylaminopropylchlorid-1    in  20 ml     Xylol    und erhitzt dann die Reaktionsmischung  weitere 2 Stunden auf l30  C.

   Nach Abkühlen schüt  telt man die Reaktionsmischung mit 20 ml einer  10%igen     Salzsäurelösung    aus, trennt die     wässrige     Schicht ab, macht sie mit konzentrierter Ammoniak  lösung alkalisch und zieht sie zweimal mit je 20 ml  Benzol aus. Man engt den     Benzolauszug    ein und       destilliert    den Rückstand unter vermindertem Druck.  Man     gewinnt    das     1,3-Dimethyl-10-(3'-dimethyl-          aminopropyl)-phenothiazin    in Form einer hellgelben,  viskosen Flüssigkeit.     Kp2    = 178  C. Das     Hydro-          chlorid    kann man z.

   B. so darstellen, dass man  die Base in gleicher Gewichtsmenge     Chlorbenzol    auf  löst und dazu das Äquivalent einer wasserfreien  ätherischen     HCI-Lösung    zusetzt. Das Hydrochlorid  bildet farblose     Nädelchen    mit F. 169  C.  



  <I>Beispiel 2</I>  Ersetzt     man    das     3-Dimethylaminopropylchlorid-1     in Beispiel 1 durch die äquivalente Menge von     2-          Dimethylaminopropylchlorid-1,    so erhält man das  1,3     -Dimethyl-10-        (2'-dimethylamino-2'-methyläthyl)-          phenothiazin    im Gemisch mit seinem     Isomeren,    dem  1,3     -Dimethyl-10-        (2'-dimethylamino-1'-methyläthyl)-          phenothiazin    [vgl.     Charpentier    und     Duerot,    C. r. 225,  306 (1947), 232, 415 (1951)].

       Kp1,2    - 203-204  C  (Base); das Hydrochlorid bildet farblose Kristalle (aus       Chlorbenzol-Äther)    mit F. 205  C     (Zers.).     



  <I>Beispiel 3</I>  Ersetzt man das     1,3-Dimethyl-phenothiazin    in  Beispiel 1 durch die äquivalente Menge von 3  Chlor-1-methyl-phenothiazin (F. 139-140 C), so  erhält man das     3-Chlor-1-methyl-10-(3'-dimethyl-          aminopropylaminopropyl)-phenothiazin.    Die Base sie  det bei 208  C/ 1     mm        Hg;    das Hydrochlorid     schmilzt     bei 177-178  C (Chlorbenzol).  



  <I>Beispiel 4</I>  Ersetzt man das     1,3-Dimethyl-phenothiazin    in  Beispiel 1 durch die äquivalente Menge von     1-Chlor-          3-methoxy-phenothiazin        (F.    132-133  C) und das       3-Dimethylaminopropylchlorid-1    durch die äquivalente.  Menge von     2-Dimethylaminopropylchlorid-1,    so er-    hält man das     1-Chlor-3-methoxy-10-(2'-dimethyl-          amino-2'-methyl-äthyl)-phenothiazin.    Das     Hydro-          chlorid    schmilzt bei 212  C.



  Process for the preparation of new 1,3-disubstituted phenothiazine derivatives The invention relates to a process for the preparation of 1,3-disubstituted phenothiazine derivatives of the formula
EMI0001.0006
    where X and Y are identical or different alkyl or alkoxyl radicals, such as methyl or methyl radicals, or one of these substituents is a halogen atom, preferably before chlorine, A is a straight or branched alkylene radical with 2-6 C atoms,

          R1 and R2 denote identical or different low molecular weight alkyl radicals which, with the N atom, can form a heterocyclic ring system which can contain a further heteroatom, which is characterized in that 1,3-disubstituted phenothiazines are used the formula
EMI0001.0024
    with aminoalkyl halides of the formula
EMI0001.0026
    where Hal is a halogen atom, or 1,

  3-disubstituted phenothiazines of the formula
EMI0001.0031
    with secondary amines of the formula
EMI0001.0032
    condensed. As a secondary amine of the formula
EMI0001.0033
    you can z. B. use dimethylamine, piperidine and similar compound.



  These connections are new. With low toxicity, they have local anesthetic, sedative, ataractic and potentiating effectiveness, which z. B. is particularly marked in thiobarbiturate anesthesia.



  The condensations are advantageous in the presence of acid-binding agents such. B. alkali metals, their hydroxides, amides, hydrides, alcoholates or organometallic compounds and in an inert organic solvent, for. B. xylene performed. The condensation also takes place without solvents and without acid-binding agents.

   The alkylaminoalkyl halides can also be used in the form of their salts with strong mineral acids, but in this case an addition of acid-binding agents in appropriate amounts is necessary.



  The new compounds prepared according to the invention can be administered in the form of their water-soluble salts with organic or inorganic acids or in the form of water-soluble addition compounds.



  <I> Example 1 </I> 1.2 g of finely ground 80% sodium amide are added to a solution of 6.8 g of 1,3-dimethylphenothiazine (mp 147 ° C.) in 40 ml of xylene The mixture is heated to 130 ° C. for 2 hours while stirring. A solution of 4 g of 3-dimethylaminopropyl chloride-1 in 20 ml of xylene is then added dropwise to this over the course of 1 hour and the reaction mixture is then heated to 130 ° C. for a further 2 hours.

   After cooling, the reaction mixture is shaken out with 20 ml of a 10% strength hydrochloric acid solution, the aqueous layer is separated off, made alkaline with concentrated ammonia solution and extracted twice with 20 ml of benzene each time. The benzene extract is concentrated and the residue is distilled under reduced pressure. The 1,3-dimethyl-10- (3'-dimethylaminopropyl) phenothiazine is obtained in the form of a pale yellow, viscous liquid. Kp2 = 178 C. The hydrochloride can e.g.

   B. represent that the base is dissolved in the same weight of chlorobenzene and the equivalent of an anhydrous ethereal HCI solution is added. The hydrochloride forms colorless needles with F. 169 C.



  <I> Example 2 </I> If the 3-dimethylaminopropyl chloride-1 in Example 1 is replaced by the equivalent amount of 2-dimethylaminopropyl chloride-1, the 1,3-dimethyl-10- (2'-dimethylamino-2) is obtained '-methylethyl) - phenothiazine in a mixture with its isomer, the 1,3-dimethyl-10- (2'-dimethylamino-1'-methylethyl) - phenothiazine [cf. Charpentier and Duerot, C. r. 225, 306 (1947), 232, 415 (1951)].

       Bp 1.2-203-204 C (base); the hydrochloride forms colorless crystals (from chlorobenzene ether) with a melting point of 205 ° C (decomp.).



  <I> Example 3 </I> If the 1,3-dimethyl-phenothiazine in Example 1 is replaced by the equivalent amount of 3 chloro-1-methyl-phenothiazine (F. 139-140 C), the 3- Chloro-1-methyl-10- (3'-dimethyl-aminopropylaminopropyl) -phenothiazine. The base is at 208 ° C / 1 mm Hg; the hydrochloride melts at 177-178 C (chlorobenzene).



  <I> Example 4 </I> If the 1,3-dimethyl-phenothiazine in Example 1 is replaced by the equivalent amount of 1-chloro-3-methoxyphenothiazine (F. 132-133 C) and the 3-dimethylaminopropyl chloride 1 by the equivalent. Amount of 2-dimethylaminopropyl chloride-1, 1-chloro-3-methoxy-10- (2'-dimethylamino-2'-methyl-ethyl) -phenothiazine is obtained. The hydrochloride melts at 212 C.

 

Claims (1)

PATENTANSPRUCH Verfahren zur Herstellung von 1,3-disubstituierten Phenothiazinabkömmlingen der Formel EMI0002.0066 wobei X und Y gleiche oder verschiedene Alkyl- oder Alkoxylreste oder einer dieser Substituenten ein Ha logenatom, A einen geraden oder verzweigten Al kylenrest mit 2-6 C-Atomen, R1 und R2 gleiche oder verschiedene niedermolekulare Alkylreste bedeuten, welche auch mit dem N-Atom ein heterocyclisches Ringsystem, PATENT CLAIM A process for the preparation of 1,3-disubstituted phenothiazine derivatives of the formula EMI0002.0066 where X and Y are identical or different alkyl or alkoxyl radicals or one of these substituents is a halogen atom, A is a straight or branched alkylene radical with 2-6 carbon atoms, R1 and R2 are identical or different low molecular weight alkyl radicals, which are also labeled with the N- Atom is a heterocyclic ring system, das noch ein weiteres Heteroatom ent halten kann, bilden können, dadurch gekennzeichnet, dass man 1,3-disubstituierte Phenothiazine der Formel EMI0002.0079 mit Aminoalkylhalogeniden der Formel EMI0002.0081 wobei Hal ein Halogenatom bedeutet, oder 1,3- disubstituierte Phenothiazine der Formel EMI0002.0086 mit sekundären Aminen der Formel EMI0002.0087 kondensiert. which can hold another heteroatom ent, characterized in that one 1,3-disubstituted phenothiazines of the formula EMI0002.0079 with aminoalkyl halides of the formula EMI0002.0081 where Hal is a halogen atom, or 1,3-disubstituted phenothiazines of the formula EMI0002.0086 with secondary amines of the formula EMI0002.0087 condensed.
CH6724258A 1957-12-20 1958-12-12 Process for the preparation of new 1,3-disubstituted phenothiazine derivatives CH373386A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS494657 1957-12-20

Publications (1)

Publication Number Publication Date
CH373386A true CH373386A (en) 1963-11-30

Family

ID=5393328

Family Applications (1)

Application Number Title Priority Date Filing Date
CH6724258A CH373386A (en) 1957-12-20 1958-12-12 Process for the preparation of new 1,3-disubstituted phenothiazine derivatives

Country Status (3)

Country Link
BE (1) BE573769A (en)
CH (1) CH373386A (en)
NL (1) NL106300C (en)

Also Published As

Publication number Publication date
BE573769A (en) 1959-04-01
NL106300C (en) 1963-09-17

Similar Documents

Publication Publication Date Title
DE2508045A1 (en) SUBSTITUTED N- (1-BENZYLPYRROLIDINYL-2-ALKYL) BENZAMIDES, METHOD FOR THE PREPARATION AND MEDICINAL PRODUCTS CONTAINING THESE
DE1018422B (en) Process for the preparation of basic substituted heterocycles
DE2426149B2 (en) 7-Fluoro-substituted phenothiazines, processes for their preparation and pharmaceutical compositions containing them
DE540697C (en) Process for the preparation of diamines acylated on one side
CH373386A (en) Process for the preparation of new 1,3-disubstituted phenothiazine derivatives
DE935546C (en) Process for the preparation of N-acyl derivatives of iminodibenzyl
CH509311A (en) (A) Cmpds.:- (I) where R2 = H, lower alkyl, or lower alkenyl n = 2-4 A = (II) or (III) in which R and R1 and H, lower alkyl or halogen;
DE2114884A1 (en) Basically substituted derivatives of 1 (2H) -phthalazinone
CH635834A5 (en) DIBENZO (D, G) (1,3,6) DIOXAZOCIN DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THE MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS.
DE1035150B (en) Process for the preparation of N-monosubstituted ª ‡ - (tert-aminoalkyl) -ª ‡ -phenyl acetamides
DE1136707B (en) Process for the preparation of N-substituted azepines
DE630842C (en) Process for the preparation of acridine droplets
DE3328186A1 (en) BASIC ACETANILIDES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE ACETANILIDES
DE881662C (en) Process for the preparation of aminoalkyl ethers of diaryl carbinols
AT151653B (en) Process for the preparation of perhydrocarbazole derivatives.
AT256116B (en) Process for the preparation of new heterocyclic compounds
AT217045B (en) Process for the preparation of new monoalkylated or monohalogenated N-derivatives of 10,11-dihydro-5H-dibenzo [b, f] azepines and 5H-dibenzo [b, f] azepines
DE1470173C (en) 1 curly bracket on 3 ge curly bracket on square bracket on 5,6,7,8 Tetrahydro 4 (arylazo) 1 naphthyl square bracket on amino curly bracket on propyl curly bracket on piperidine compounds, their acid addition salts and process for their production
DE953798C (en) Process for the preparation of new disubstituted nicotinic acid amides
DE1518652A1 (en) Process for the preparation of pharmaceutically active derivatives of 2-aminoindane
DE954424C (en) Process for the preparation of alkylaminoalkyl esters of aminooxybenzoic acids
DE954599C (en) Process for the preparation of derivatives of 5-amino-8-methyl-thiochromanone and thiochromone
AT311345B (en) Process for the preparation of new, heterocyclic aminophenylalkylamines and of their acid addition salts
CH310649A (en) Process for the preparation of a 2-halo-4-aminotoluene.
DEC0006830MA (en)